Difficulty: Medium
Average Score: 79%
Practice
To avoid false-negative skin test results in atopic hosts, most sedating antihistamines should be withheld for 3-4 days, and non-sedating antihistamines for 5-7 days while montelukast should be withheld for
Correct answer
C
Rationale
The correct answer is C) 5 days. When administering skin tests in atopic hosts, it is crucial to withhold certain medications to prevent false-negative results. Montelukast, a leukotriene receptor antagonist, should be withheld for 5 days prior to skin testing.
Providing an educational context, sedating antihistamines are withheld for 3-4 days because they can interfere with skin test results due to their sedative properties. Non-sedating antihistamines should be withheld for 5-7 days as they can also impact the accuracy of skin tests. Montelukast, although not an antihistamine, should be withheld for 5 days to ensure accurate skin test results.
Option A) 1 day is incorrect because withholding montelukast for only 1 day may not be sufficient to prevent interference with skin test results. Option B) 3 days is incorrect as this timeframe is more appropriate for sedating antihistamines, not montelukast. Option D) 7 days is incorrect as it exceeds the recommended withholding period for montelukast, potentially delaying necessary treatment for the patient.
Understanding the appropriate withholding periods for medications in skin testing is crucial for healthcare providers working with pediatric patients to ensure accurate diagnostic results and effective treatment plans.
Providing an educational context, sedating antihistamines are withheld for 3-4 days because they can interfere with skin test results due to their sedative properties. Non-sedating antihistamines should be withheld for 5-7 days as they can also impact the accuracy of skin tests. Montelukast, although not an antihistamine, should be withheld for 5 days to ensure accurate skin test results.
Option A) 1 day is incorrect because withholding montelukast for only 1 day may not be sufficient to prevent interference with skin test results. Option B) 3 days is incorrect as this timeframe is more appropriate for sedating antihistamines, not montelukast. Option D) 7 days is incorrect as it exceeds the recommended withholding period for montelukast, potentially delaying necessary treatment for the patient.
Understanding the appropriate withholding periods for medications in skin testing is crucial for healthcare providers working with pediatric patients to ensure accurate diagnostic results and effective treatment plans.